Despite Incremental Improvements, the Promise of Smart Infusion Remains an Elusive Goal

(Amherst, NH) – Infusion remains one of the most common in-patient procedures and a technology that has been around for decades, yet the nature of IV drug delivery continues to be a major source of errors – one that appears to be refractory to industry efforts to eliminate them. While other healthcare segments have been quick to see significant gains from the uptake of evolving technologies such as miniaturized electronics, sophisticated software programming and wireless connectivity, the rate of change for infused drug delivery at times seems to be occurring at an osmotic pace.

In an attempt to reduce infusion errors, manufacturers have developed pumps that have Dose Error Reduction Systems, which include hospital-defined drug libraries with dosing limits and other clinical advisories integrated into the system (i.e., smart pumps). Smart pumps, particularly those with bar code readers, are assumed to simplify aspects of the drug administration process. However, smart infusion systems may add to the demands of the overall drug administration process or, in some cases, introduce completely new tasks that may introduce a new source of errors.

Connected infusion management offers the clinician the ability to associate or connect an infusion device to a patient, a medication, or a continuous infusion order, and to have volumes and titrations automatically stream to the EHR from the IV pump. It offers the ability to gather real-time data from multiple sources into a single location. Smart pump device vendors have to validate their products' performance on wireless networks. The extent of validation required depends on the nature of the data. Continuous patient monitoring, or any device that can generate vital signs alarms, must be extensively tested to ensure safe performance.

The evolving market for smart infusion devices is detailed in a new and comprehensive report researched and written by Greystone Research Associates. Smart Infusion Pumps: Products, Markets, Players, Strategies and Forecasts analyzes the global market for these innovative devices. The report also assesses key therapeutic market segments, analyzes demand drivers, development factors, market considerations, and economic factors, and provides profiles of market sector participants.

More information is available at http://www.greystoneassociates.org


Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.